Intestinal absorption of pallidifloside D are limited by P-glycoprotein in mice
- 3 August 2017
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 48 (7) , 739-744
Abstract
1. Pallidifloside D, a saponin glycoside constituent from the total saponins of Smilax riparia, had been proved to be very effective in hyperuricemic control. But it is poorly bioavailable after oral administration. Here, we determined the role of P-glycoprotein (P-gp) in the intestinal absorption of Pallidifloside D. 2. We found that Pallidifloside D significantly stimulated P-gp ATPase activity in vitro ATPase assay with a small EC50 value of 0.46 μM. 3. In the single-pass perfused mouse intestine model, the absorption of Pallidifloside D was not favored in the small intestine (duodenum, jejunum and ileum) with a P*w value of 0.35–0.78. By contrast, this compound was well-absorbed in the colon with a P*w value of 1.23. The P-gp inhibitors cyclosporine significantly enhanced Pallidifloside D absorption in all four intestinal segments (duodenum, jejunum, ileum and colon) and the fold change ranged from 5.5 to 15.3. Pharmacokinetic study revealed that cyclosporine increased the systemic exposure of Pallidifloside D by a 2.5-fold after oral administration. 4. These results suggest that P-gp-mediated efflux is a limiting factor for intestinal absorption of Pallidifloside D in mice.Keywords
This publication has 35 references indexed in Scilit:
- P-glycoprotein Inhibition for Optimal Drug DeliveryDrug Target Insights, 2013
- Treatment of Diabetes Using Traditional Chinese Medicine: Past, Present and FutureThe American Journal of Chinese Medicine, 2012
- Enhancement of Oral Bioavailability of 20(S)-Ginsenoside Rh2 through Improved Understanding of Its Absorption and Efflux MechanismsDrug Metabolism and Disposition, 2011
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- Disposition of Naringenin via Glucuronidation Pathway Is Affected by Compensating Efflux Transporters of Hydrophilic GlucuronidesMolecular Pharmaceutics, 2009
- A prospective study of gout and cancerEuropean Journal Of Cancer Prevention, 2009
- Unbiased membrane permeability parameters for gabapentin using boundary layer approachThe AAPS Journal, 2005
- Profile of P‐glycoprotein Distribution in the Rat and Its Possible Influence on the Salbutamol Intestinal Absorption IrocessJournal of Pharmaceutical Sciences, 2004
- Metabolism of Flavonoids via Enteric Recycling: Role of Intestinal DispositionThe Journal of Pharmacology and Experimental Therapeutics, 2003
- MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability ScreeningJournal of Pharmaceutical Sciences, 1999